Results 151 to 160 of about 18,375 (295)

Social Comparison and Its Association With Disordered Eating Symptoms: A Systematic Review and Meta‐Analysis

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Social comparison has been widely implicated in the etiology and maintenance of body dissatisfaction and eating disorders. At the same time, however, the magnitude of this relationship remains unclear, with existing studies varying widely in methodology, measurement, and sample characteristics.
Fidan Turk   +5 more
wiley   +1 more source

Highly Processed Foods in Binge‐Eating Episodes: The Importance of Improving Food Reporting

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Over the past 60 years, the proportion of highly processed foods rich in refined carbohydrates and added fats in the food environment has increased, coinciding with a rise in binge eating. While past research has focused on individual vulnerabilities for binge eating, emerging evidence suggests highly processed foods may exacerbate ...
Ingrid A. Worth   +4 more
wiley   +1 more source

A Network Approach to Support Sustainability Policy Coordination: Exploring Linkages Between Biodiversity Indicators and Essential Biodiversity Variables

open access: yesEnvironmental Policy and Governance, EarlyView.
ABSTRACT Global sustainability policy demands coordination among domain‐specific policies, yet a major challenge persists in policy monitoring and reporting, where various, often uncoordinated indicator initiatives exist. To address this challenge, we apply a network approach to investigate linkages between the indicators of the Sustainable Development
André Mascarenhas   +4 more
wiley   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy